Business Development Manager Asia | IDL Biotech
IDL Biotech

CLOSE MENU

Articles

Typhiod fever

August 2020

Business Development Manager Asia

IDL Biotech has appointed Subyung Park as Business Development Manager Asia with a focus on the product TUBEX® TF.

Read the press release here

IDL Biotech signs distributor agreement in Ghana

IDL Biotech continues to expand in Africa. IDL Biotech has signed a distributor agreement with Res Health Consult Ltd covering Ghana. The agreement covers the sale of TUBEX® TF.

IDL Biotech includes additional clinics in its ongoing multicenter study for UBC® Rapid in Sweden.

IDL Biotech currently has a number of ongoing clinical studies both internationally and in Sweden, with the aim of demonstrating the clinical benefit of UBC® Rapid in bladder cancer and having the test included as a complement in the follow-up of patients with bladder cancer who are classified as high risk.

IDL Biotech

Skip this intro